Could a common antioxidant save newborns from deadly sepsis?
NCT ID NCT07380347
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether adding N-acetylcysteine (NAC) to standard care helps newborns with sepsis. Sepsis causes dangerous inflammation and cell damage. NAC may reduce this damage by boosting the body's defenses. The trial will enroll 50 near-term and term infants to see if NAC improves organ function, lowers hospital stay, and reduces death.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEONATAL SEPSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a higher steroid dose help preterm babies breathe easier?
- Quick blood tests could save newborns from sepsis
- Kidney injury prediction study for sick kids withdrawn before starting
- Which hand rub saves more tiny lives? new trial aims to find out
- Tiny blood test could predict deadly sepsis in preterm infants
- Booster shot for Moms-to-Be could shield newborns from deadly infections